The pathophysiology of motor symptoms in Parkinson's disease

Acta Neurologica Belgica

Volumn 103, Issue 3, 2003, Pages 129-134

  Santens, Patrick ^a   Boon, P ^a   Van Roost, D ^a   Caemaert, J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRADYKINESIA; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; EXTRAPYRAMIDAL SYNDROME; HUMAN; HYPOKINESIA; LONG TERM POTENTIATION; MOTOR DYSFUNCTION; MOUSE; MUSCLE RIGIDITY; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREDICTION; REVIEW; TREMOR;

EID: 0242692559     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Abbruzzese G., Berardelli A. Sensorimotor integration in movement disorders. Mov. Disord., 2003, 18 : 231-240.
2. Alexander G. E., Crutcher A D. Functional architecture of basal ganglia circuits : neural substrates of parallel processing. Tr. Neurosci., 1990, 13 : 266-271.
3. Bara-Jimenez W., Sherzai A., Dimitrova T., Favit A., Bibbiani F., Gillespie M, Morris M. J., Mouradian M. M., Chase T. N. Adenosine A2A receptor antagonist treatment of Parkinson's disease. Neurology, 2003, 61 : 293-296.
4. Bedard P. J., Blanchet P. J., Levesque D., Soghomonian J. J., Grondin R., Morissette M., Goulet M., Calon F., Falardeau P., Gomez-Mancilla B., Doucet J. P., Robertson G. S., Dipaolo T. Pathophysiology of L-dopa-induced dyskinesias. Mov. Disord., 1999, 14 Suppl. 1 : 4-8.
5. Berardelli A., Rothwell J. C., Thompson P. D., Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain, 2001, 124 : 2131-2146.
6. Bergman H., Deuschl G. Pathophysiology of Parkinson's disease : from clinical neurology to basic neuroscience and back. Mov. Disord., 2002, 17 Suppl 3 : S28-S40.
7. Brooks D., Playford E. D., Ibanez V., Sawle G., Thompson P. D., Findley L. J., Marsden C. D. Isolated tremor and disruption of the nigrostriatal dopaminergic system : an 18F-DOPA PET study. Neurology, 1992, 42 : 1554-1560.
8. Brown P. Oscillatory nature of human basal ganglia activity : relationship to the pathophysiology of Parkinson's disease. Mov. Disord., 2003, 18 : 357-363.
9. Brown P., Marsden C. D. What do the basal ganglia do ? Lancet, 1998, 351 : 1801-1804.
10. De Letter M., Santens P., Van Borsel J. The effects of levodopa on tongue strength and endurance in patients with Parkinson's disease. Acta Neurol. Belg., 2003, 103 : 35-38.
11. Deiber A P., Pollak P., Passingham R., Landais P., Gervason C., Cinotti L., Friston K., Frackowiak R., Mauguiere F., Benabid A. L. Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain, 1993, 116 (Pt 1) : 267-279.
12. Delong M. Primate models of movement disorders of basal ganglia origin. Tr. Neurosci., 1990,13 : 281-285.
13. Delwaide P., Pepin J. L., Maertens de Noordhout A. LA rigidité parkinsonienne: aspects cliniques et physiopathologiques. Rev. Neurol., 1990, 146 : 548-554.
14. Delwaide P., Pepin J. L., Maertens de Noordhout A. The audiospinal reaction in parkinsonian patients reflects functional changes in reticular nuclei. Ann. Neurol., 1993, 33 : 63-69.
15. Deuschl G., Bain P., Brin M., Scientific Committee Consensus statement of the movement disorder society on tremor. Mov. Disord., 1998, 13 (suppl 3) : 2-23.
16. Deuschl G., Raethjen J., Baron R., Lindemann M., Wilms H., Krack P. The pathophysiology of parkinsonian tremor: a review. J. Neurol., 2000, 247 (suppl V) : 33-48.
17. 11C-WAY 100635 PET study. Neurology, 2003, 60 : 601-605.
18. Elble R. J. Tremor and dopamine agonists. Neurology, 2002, 58 : S57-S62.
19. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann. Neurol., 2000, 47 (suppl. 1) : 3-11.
20. Graybiel A. M., Canales J. J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Tr. Neurosci., 2000, 23 (suppl.) : S71-S77.
21. Jahnsen H., Llinas R. Ionic basis for the electro-responsiveness and oscillatory properties of of guinea pig thalamic neurones in vitro, J. Physiol., 1984, 349 : 227-247.
22. Magnin M., Morel, A., Jeanmonod D. Single-unit analysis of the pallidum,thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience, 2000, 96 : 549-564.
23. Marsden C. D., Parkes J. D. Succes and problems of long-term levodopa therapy in parkinson's disease. Lancet, 1977, 345-349.
24. Obeso J. A., Olanow C. W., Nutt J. G. Levodopa motor complications in Parkinson's disease. Tr. Neurosci., 2000a, 23 (suppl.) : S2-S7.
25. Obeso J. A., Rodriguez-Oroz M. C., Rodriguez M., Lanciego J. I., Artieda J., Gonzalo N., Olanow C. W. Pathophysiology of the basal ganglia in Parkinson's disease. Tr. Neurosci., 2000b, 23 (suppl.) : S8-S19.
26. Pahapill P. A., Lozano A. M The pedunculopontine nucleus and Parkinson's disease. Brain, 2000, 123 : 1767-1783.
27. Pfann K. D., Buchman A. S., Comella C., Corcos D. M. Control of movement distance in Parkinson's disease. Mov. Disord., 2001, 16 : 1048-1065.
28. Plenz D., Kital S. T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature, 1999, 400 : 677-682.
29. Salenius S., Avikainen S., Kaakkola S., Hari R., Brown P. Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa. Brain, 2002, 125 : 491-500.
30. Vingerhoets G., Verleden S., Santens P., Miatton M., De Reuck J. Predictors of cognitive impairment in advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 2003, 74 : 793-796.
31. Walters J. R., Ruskin D. N., Allers K. A., Bergstrom D. A. Pre-and postsynaptic aspects of dopamine-mediated transmission. Tr. Neurosci., 2000, 23 (suppl.) : S41-S47.